Julie Ann Dopheide, PharmD, BCPP, FASHP
Faculty Directory

Julie Ann DopheidePharmD, BCPP, FASHP

Julie Ann DopheidePharmD, BCPP, FASHP

Professor of Clinical Pharmacy

Titus Family Department of Clinical Pharmacy

Julie Dopheide is a board-certified psychiatric pharmacist who provides clinical service for adults and children with psychiatric illness at Los Angeles County+USC Medical Center. Her research has included assessing the tolerability of valproate loading doses and expanding direct patient care roles for psychiatric pharmacists. She served as USC’s PGY2 Psychiatric Pharmacy Residency program director from 1998-2022 and currently supervises pharmacy residents and students in the provision of comprehensive medication management on the inpatient psychiatry service and in clinics. She is actively involved in teaching pharmacy students, medical students, allied health, and psychiatry residents in both the classroom and clinical settings.

Dopheide’s excellence as an educator is recognized nationally and internationally. She has more than 40 publications in peer-reviewed journals, textbooks and educational resources. She has been a visiting professor at Tokyo University of Pharmacy and Life Sciences and twice served as a healthcare manpower development expert for the Ministry of Health in Singapore. She serves as an invited speaker for several national pharmacy organizations including the American Pharmacists Association, the American Society of Health System Pharmacists, and the American Association of Psychiatric Pharmacy (formerly College of Psychiatric and Neurologic Pharmacy-CPNP). She actively contributes items to the Board of Pharmacy Specialties Examination for Psychiatric Pharmacy and served as chair (2021-2022) and vice-chair of the psychiatric specialty council.  She served as president of CPNP in 2013-2014.

Areas of Expertise

  • Eating Disorders
  • Insomnia and Sleep Disorders
  • Depression and Bipolar Disorder
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Autism Spectrum Disorder (Asd)
  • Comprehensive Medication Managment
  • Education

    University of Southern California

    Residency

    University of Nebraska

    PharmD

  • Links
  • Research Focus

    Tolerability of Psychotropics

    Dr. Dopheide's research includes investigating the tolerability of psychotropics and expanding roles for board certified psychiatric pharmacists to improve patient's health outcomes

  • Selected Articles

    Do pharmacist employers prefer or require board certification?

    Journal of the American Pharmacists Association
    Fay Goldenshteyn, Julie Ann Dopheide, Mimi Lou

    2019 The pharmacy profession has promoted the value of board certification, yet the impact of board certification on employment opportunities for pharmacists is largely unknown. This study aims to report employer preferences for board certification as indicated on job listings.

    Read More

    Pharmacy resident teaching in psychiatry and neurology for pharmacy programs in the United States

    The Mental Health Clinician
    Julie Ann Dopheide

    2018 The American Society of Health-System Pharmacists' Postgraduate Year 1 and Year 2 Residency Accreditation Standards require that residents demonstrate effective teaching skills. The College of Psychiatric and Neurologic Pharmacists' survey of pharmacy program curricula assessed resident teaching in psychiatry and neurology, however, results were not published. The objective of this article is to describe resident teaching in psychiatry and neurology curricula as reported by responses to the college's survey.

    Read More

    Curriculum in Psychiatry and Neurology for Pharmacy Programs

    American Journal of Pharmaceutical Education
    Julie Ann Dopheide; Lisa W Goldstone

    2017 To describe pharmacy curricula in psychiatry and neurology and to report on neuropsychiatric pharmacy specialists' views on optimal curriculum. Design and administer one electronic survey to accredited pharmacy programs asking them to report information on curricula in psychiatry and neurology for the 2014-2015 academic year. Design and administer a separate electronic survey to board certified pharmacists with an academic affiliation who are members of the College of Psychiatric and Neurologic Pharmacists (CPNP) asking about their teaching activities and their opinion on optimal curricula. Fifty-six percent of pharmacy programs and 65% of CPNP members responded to the surveys. The program survey revealed greater than 80% of topics were taught by full-time faculty. Didactic lecturing, team-based learning, and case studies were the most common teaching methods. Programs dedicated the most didactics (3 to 5+ hours) to epilepsy, depression, schizophrenia, substance use disorders, and pain. Autism, traumatic brain injury, personality, and eating disorders were either not taught or given ≤ 1 hour of didactics in most programs. Inpatient psychiatry had the most APPE placements with a mean of 19.6, range 0-83. APPE electives in psychiatry outnumbered those in neurology 5 to 1. CPNP member survey results showed 2 out of 3 members agreed that curriculum could be improved with additional APPEs in psychiatry and neurology. Didactic hour distribution in psychiatry and neurology could be improved to better align with board certification in psychiatric pharmacy (BCPP) recommendations and disorder prevalence and complexity. Specialists recommend an experiential component in neurology and psychiatry to combat stigma and improve pharmacist knowledge and skills.

    Read More

    Antipsychotic Selection for Acute Agitation and Time to Repeat Use in a Psychiatric Emergency Department

    Journal of Psychiatric Practice
    Julie Ann Dopheide

    2016 Early recognition and treatment of agitated patients is essential to avoid violence in the psychiatric emergency department (ED). Antipsychotics have established efficacy in managing agitation, yet little is known about how the choice of initial antipsychotic impacts time to repeat use and length of stay (LOS) in the psychiatric ED.

    Read More

    Acetylcysteine for treatment of autism spectrum disorder symptoms

    Am J Health Syst Pharm

    2015 A 17-year-old Hispanic male with ASD and intellectual disability was hospitalized for inpatient psychiatric treatment due to impulsive and violent behavior. Despite receiving various medications in the initial weeks of hospitalization, including intramuscular lorazepam and diphenhydramine injections (four days a week on average), the patient continued to exhibit aggressive and unpredictable behaviors.

    Read More

    Nonpsychiatric medication interventions initiated by a postgraduate year 2 psychiatric pharmacy resident in a patient-centered medical home.

    The Primary Care Companion for CNS Disorders
    Williams AM, Dopheide JA

    2014 Studies have demonstrated the benefits of incorporating comprehensive medication management into primary care, but no study describes the types of nonpsychiatric medication-related interventions provided by a psychiatric pharmacist while providing comprehensive medication management.

    Read More

    Psychiatric pharmacist management of depression in patients with diabetes.

    The Primary Care Companion for CNS Disorders
    Nazarian PK, Dopheide JA

    2013

    Read More

    Depression Screening in a University Campus Pharmacy: A Pilot Project

    Journal of the American Pharmacists Association
    Dopheide JA, Werremeyer A, Haight RJ, Gutierrez CA, Williams AM.

    2006 To evaluate the usefulness of a depression screening tool in a university campus pharmacy.

    Read More

    "Positioning Psychiatric Pharmacists to Improve Mental Health Care"

    Ment Health Clin. 2022 Apr 14;12(2):77-85. doi: 10.9740/mhc.2022.04.077. PMID: 35582321; PMCID: PMC9009818.

    Board Certified Psychiatric Pharmacist Integration in Health Systems Can Improve Mental Health Care.

    Read More

    Factors influencing performance on the Board Certified Psychiatric Pharmacist Examination: Passing rates and domain-level scores.

    Ment Health Clin [Internet]. 2021;11(6):358-64. DOI: 10.9740/mhc.2021.11.358

    Muckle TJ, Dopheide JA, Gable K, Meng Y, Johnson SG, Ellis W.

    Read More

    “Changing Manufacturer to Address Nonclozapine Antipsychotic Neutropenia: case reports”.

    Journal of the American Pharmacists Association 2022. https://doi.org/10.1016/j.japh.2022.04.010

    Antipsychotics manufactured by different companies include different fillers and excipients. Two cases are presented where neutropenia improves when the patient transitions from one manufacturer of the antipsychotic to a different manufacturer. The authors propose, these different ingredients may contribute to the development of neutropenia from antipsychotics.

    Read More

  • Affiliations
    • Vice-chair Board of Pharmacy Specialties (BPS) Psychiatric Specialty Council: 2019-2021

    • American Society of Hospital Pharmacists : Member

    • American Pharmacists Association : Member

    • American Association of Colleges of Pharmacy : Member

    • NAMI : Member

    • College of Psychiatric and Neurologic Pharmacists: Member

    • College of Psychiatric and Neurologic Pharmacists Foundation: Founding Member

  • Accomplishments

    Recipient of the College of Psychiatric and Neurologic Pharmacists

    2020 Judith J. Saklad Memorial award for achieving a level of professional distinction as a senior psychiatric pharmacist

    Advanced Practice Pharmacy Experience Preceptor of the Year

    2017 - 20182001 - 2002

    Professor of the Year

    2015

    President of the College of Psychiatric and Neurologic Pharmacists

    2013 - 2014

  • Research Grants

    PGY2 Resident Research

    Board of Pharmacy Specialties,

    2018-2019

    Support an additional PGY2 resident

    AMGEN,

    2010-2011

  • Selected Media Appearances

    Empathy, tech combine to improve autism awareness and research

    USC News | 03/31/2017

    “Thanks to improved public health education on autism spectrum disorder, most parents and providers now recognize that vaccines do not cause ASD. Potential causes are many and include genetics and toxins in the environment"...

    Read More

    Counseling Points for Treating Patients with Depression, Anxiety and Insomnia

    Pharmacy Times | 03/07/2016

    Julie Dopheide, PharmD, BCPP, FASHP, outlines several counseling points for treating patients with depression, anxiety and insomnia...

    Read More